EUVIMEDEUVIMED entdecken
Crossref

Changes in Isoleucine, Sarcosine, and Dimethylglycine During OGTT as Risk Factors for Diabetes

Yixian Liu, Xiaoxuan Liu, Qian He, Xu Huang, Yanv Ren, Zuoliang Dong iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Yixian Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Tianjin Medical University General Hospital, Heping District, Tianjin 300052, China. Hauptthemen laut MEDLINE: Glucose Tolerance Test, Diabetes Mellitus, Type 2, Isoleucine, Sarcosine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Current metabolomics studies in diabetes have focused on the fasting state, while only a few have addressed the satiated state.

Objective

We combined the oral glucose tolerance test (OGTT) and metabolomics to examine metabolite-level changes in populations with different glucose tolerance statuses and to evaluate the potential risk of these changes for diabetes.

Methods

We grouped participants into those with normal glucose tolerance (NGT), impaired glucose regulation (IGR), and newly diagnosed type 2 diabetes (NDM). During the OGTT, serum was collected at 0, 30, 60, 120, and 180 minutes. We evaluated the changes in metabolite levels during the OGTT and compared metabolic profiles among the 3 groups. The relationship between metabolite levels during the OGTT and risk of diabetes and prediabetes was analyzed using a generalized estimating equation (GEE). The regression results were adjusted for sex, body mass index, fasting insulin levels, heart rate, smoking status, and blood pressure.

Results

Glucose intake altered metabolic profile and induced an increase in glycolytic intermediates and a decrease in amino acids, glycerol, ketone bodies, and triglycerides. Isoleucine levels differed between the NGT and NDM groups and between the NGT and IGR groups. Changes in sarcosine levels during the OGTT in the diabetes groups were opposite to those in glycine levels. GEE analysis revealed that during OGTT, isoleucine, sarcosine, and acetic acid levels were associated with NDM risks, and isoleucine and acetate levels with IGR risks.

Conclusion

Metabolic profiles differ after glucose induction in individuals with different glucose tolerance statuses. Changes in metabolite levels during OGTT are potential risk factors for diabetes development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucose Tolerance TestDiabetes Mellitus, Type 2IsoleucineSarcosineBlood GlucoseGlucose IntoleranceHumansMaleFemaleMiddle AgedRisk FactorsAdultPrediabetic StateMetabolomicsAgedBiomarkers

Stichwörter der Autor:innen

impaired glucose regulationmetabolomicsoral glucose tolerance testtype 2 diabetes

Substanzen

IsoleucineSarcosineBlood GlucosedimethylglycineBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Tianjin Medical University General Hospital, Heping District, Tianjin 300052, China.
  • School of Medical Imaging, Tianjin Medical University, No.1 Guangdong Road, Hexi District, Tianjin, 300204, China.

ORCID-Profile: Zuoliang Dong

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Liu, Y., Liu, X., He, Q., Huang, X., Ren, Y., & Dong, Z. (2024). Changes in Isoleucine, Sarcosine, and Dimethylglycine During OGTT as Risk Factors for Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae018

Vancouver

Liu Y, Liu X, He Q, Huang X, Ren Y, Dong Z. Changes in Isoleucine, Sarcosine, and Dimethylglycine During OGTT as Risk Factors for Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae018

BibTeX
@article{Liu2024,
  author = {Liu, Yixian and Liu, Xiaoxuan and He, Qian and Huang, Xu and Ren, Yanv and Dong, Zuoliang},
  title = {Changes in Isoleucine, Sarcosine, and Dimethylglycine During OGTT as Risk Factors for Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae018}
}
Kostenlos starten →